Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 101–200 of 1,011
Tumor progression and metastasis
Yokota, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.497 · Cited by 426
A highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Beginning to Understand the End of the Chromosome
Cech, T. R. (2004) · Cell · doi:10.1016/s0092-8674(04)00038-8 · Cited by 421
Chemosensitivity linked to p73 function
Irwin, M. S., Kondo, K., Marin, M. C., Cheng, L. S., Hahn, W. C., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00078-3 · Cited by 408
Self-citationCellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.188102 · Cited by 389
RALA and RALBP1 regulate mitochondrial fission at mitosis
Kashatus, D. F., Lim, K.-H., Brady, D. C., Pershing, N. L. K., Cox, A. D., & Counter, C. M. (2011) · Nature Cell Biology · doi:10.1038/ncb2310 · Cited by 380
Self-citationAn RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Maida, Y., Yasukawa, M., Furuuchi, M., Lassmann, T., Possemato, R., Okamoto, N., Kasim, V., Hayashizaki, Y., Hahn, W. C., & Masutomi, K. (2009) · Nature · doi:10.1038/nature08283 · Cited by 384
Self-citationInterplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Di Micco, R., Sulli, G., Dobreva, M., Liontos, M., Botrugno, O. A., Gargiulo, G., dal Zuffo, R., Matti, V., d'Ario, G., Montani, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2170 · Cited by 382
Self-citationTumor suppressors and oncogenes in cellular senescence
Bringold, F., & Serrano, M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00083-8 · Cited by 379
Function of the c-Myc Oncogenic Transcription Factor
Dang, C. V., Resar, L. M. S., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., & Zeller, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4686 · Cited by 379
Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376
“In both cell culture models and animal models, activated ras cooperates with other oncogenic genetic alterations to induce transformation (13, 19, 25, 49, 57, 61).”
BackgroundShi, S., Gronthos, S., Chen, S., Reddi, A., Counter, C. M., Robey, P. G., & Wang, C.-Y. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-587 · Cited by 376
Self-citationPanich, U., Sittithumcharee, G., Rathviboon, N., & Jirawatnotai, S. (2016) · Stem Cells International · doi:10.1155/2016/7370642 · Cited by 374
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
Shuda, M., Kwun, H. J., Feng, H., Chang, Y., & Moore, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46323 · Cited by 374
González‐Suárez, E., Samper, E., Ramírez, A., Flores, J. M., Martín‐Caballero, J., Jorcano, J. L., & Blasco, M. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2619 · Cited by 372
“Furthermore, TERTmediated telomerase activation is able to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells ( Hahn et al., 1999 ).”
BackgroundOncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Dimri, G. P., Martínez‐Guitarte, J., Jacobs, J. J. L., Keblusek, P., Itahana, K., van Lohuizen, M., Campisi, J., Wazer, D. E., & Band, V. (2002) · PubMed · Cited by 396
Hirsch, H. A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S. A., Bulyk, M., Tsichlis, P. N., Shirley Liu, X., & Struhl, K. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.022 · Cited by 359
Post-prenylation-processing enzymes as new targets in oncogenesis
Winter-Vann, A. M., & Casey, P. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1612 · Cited by 357
Signaling Pathways in Cancer and Embryonic Stem Cells
Dreesen, O., & Brivanlou, A. H. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0004-8 · Cited by 357
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Ramanathan, A., Wang, C., & Schreiber, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502267102 · Cited by 357
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355
“Given the importance of RalGEF activation for trans-topically express hTERT, T-Ag and t-Ag (Hahn et al., 1999). formation of human cells, understanding how the RalGEF on-These cells provide a genetically defined human cell system to cogenic signal is transmitted could provide insight into the assay…”
InfluentialSelf-citationCancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352
Natural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A. (2000) · Nature Genetics · doi:10.1038/79089 · Cited by 347
A mutator phenotype in cancer.
Loeb, L. A. (2001) · PubMed · Cited by 950
Cheng, E., Zhang, X., Huo, X., Yu, C., Zhang, Q., Wang, D. H., Spechler, S. J., & Souza, R. F. (2013) · Gut · doi:10.1136/gutjnl-2012-302250 · Cited by 348
Contribution of stem cells and differentiated cells to epidermal tumours
Owens, D. M., & Watt, F. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1096 · Cited by 346
Löhr, M., Klöppel, G., Maisonneuve, P., Lowenfels, A. B., & Lüttges, J. (2005) · Neoplasia · doi:10.1593/neo.04445 · Cited by 343
Mucin Gene Expression in Immortalized Human Corneal–Limbal and Conjunctival Epithelial Cell Lines
Gipson, I. K., Spurr-Michaud, S., Argu¨eso, P., Tisdale, A., Ng, T. F., & Russo, C. L. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0851 · Cited by 345
Rheinwald, J. G., Hahn, W. C., Ramsey, M. R., Wu, J. Y., Guo, Z., Tsao, H., De Luca, M., Catricalà, C., & O'Toole, K. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5157-5172.2002 · Cited by 338
“form of cdk4 (61, 74); and pBABE(hTERT)puro, which expresses the catalytic subunit of human telomerase (17, 24 ).”
BackgroundRachakonda, P. S., Hosen, I., de Verdier, P. J., Fallah, M., Heidenreich, B., Ryk, C., Wiklund, N. P., Steineck, G., Schadendorf, D., Hemminki, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310522110 · Cited by 340
A mechanistic classification of clinical phenotypes in neuroblastoma
Ackermann, S., Cartolano, M., Hero, B., Welte, A., Kahlert, Y., Roderwieser, A., Bartenhagen, C., Walter, E., Gecht, J., Kerschke, L., et al. (2018) · Science · doi:10.1126/science.aat6768 · Cited by 335
Mitochondria as therapeutic targets for cancer chemotherapy
Galluzzi, L., Larochette, N., Zamzami, N., & Kroemer, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209598 · Cited by 337
The granulin gene family: from cancer to dementia
Bateman, A., & Bennett, H. P. J. (2009) · BioEssays · doi:10.1002/bies.200900086 · Cited by 337
Telomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
Self-citationErosion of the telomeric single-strand overhang at replicative senescence
Stewart, S. A., Ben-Porath, I., Carey, V. J., O'Connor, B. F., Hahn, W. C., & Weinberg, R. A. (2003) · Nature Genetics · doi:10.1038/ng1127 · Cited by 335
“We introduced TERT and T-Ag into the cells as previously describe”
MethodSelf-citationOncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation
Ogrunc, M., Di Micco, R., Liontos, M., Bombardelli, L., Mione, M., Fumagalli, M., Gorgoulis, V. G., & d'Adda di Fagagna, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.16 · Cited by 328
Identification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325
“Immortalized human fibroblasts (BJ) expressing hTERT as previously described (Hahn et al., 1999).”
BackgroundMethodSelf-citationHealing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201266200 · Cited by 326
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
Vazquez, A., Liu, J., Zhou, Y., & Oltvai, Z. N. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-58 · Cited by 319
Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia
Wei, J., Wunderlich, M., Fox, C., Alvarez, S., Cigudosa, J. C., Wilhelm, J. S., Zheng, Y., Cancelas, J. A., Gu, Y., Jansen, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.020 · Cited by 284
A critical role for telomeres in suppressing and facilitating carcinogenesis
Artandi, S. E., & DePinho, R. A. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00047-7 · Cited by 318
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Self-citationRetractedImmortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype
Ouyang, H., Mou, L.-J., Luk, C., Liu, N., Karaskova, J., Squire, J., & Tsao, M.-S. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64800-6 · Cited by 313
Resistance to chemotherapy: new treatments and novel insights into an old problem
Raguz, S., & Yagüe, E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604510 · Cited by 312
What has senescence got to do with cancer?
Dimri, G. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.025 · Cited by 313
Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309
Self-citationThe Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor
Zhou, X. Z., & Lu, K. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00538-4 · Cited by 309
Mathon, N. F., & Lloyd, A. C. (2001) · Nature Reviews Cancer · doi:10.1038/35106045 · Cited by 308
Cellular senescence as a tumor-protection mechanism: the essential role of counting
Wright, W. E., & Shay, J. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00163-5 · Cited by 306
Ostenfeld, T., Caldwell, M. A., Prowse, K. R., Linskens, M. H., Jauniaux, E., & Svendsen, C. N. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7427 · Cited by 304
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
Iwanicki, M. P., Davidowitz, R. A., Ng, M. R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., & Brugge, J. S. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0010 · Cited by 303
DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly
Litovchick, L., Florens, L. A., Swanson, S. K., Washburn, M. P., & DeCaprio, J. A. (2011) · Genes & Development · doi:10.1101/gad.2034211 · Cited by 302
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky, G. A., Chenette, E. J., & Der, C. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.014 · Cited by 300
Niemann, C., Owens, D. M., Hülsken, J., Birchmeier, W., & Watt, F. M. (2002) · Development · doi:10.1242/dev.129.1.95 · Cited by 298
Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells
Liu, P., Ramachandran, S., Ali Seyed, M., Scharer, C. D., Laycock, N., Dalton, W. B., Williams, H., Karanam, S., Datta, M. W., Jaye, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3055 · Cited by 295
Astle, M. V., Hannan, K. M., Ng, P. Y., Lee, R. S., George, A. J., Hsu, A. K., Haupt, Y., Hannan, R. D., & Pearson, R. B. (2012) · Oncogene · doi:10.1038/onc.2011.394 · Cited by 295
“BJ-T cells, a gift from Robert Weinberg, and derivatives were cultured in Dulbecco’s modified Eagle’s medium:M199 media at a ratio of 4:1 (v/v) with 15% fetal calf serum and 2mM L-glutamine (Hahn et al., 1999, 2002) and maintained in 5% CO2 at 37 1C. Cells expressing pBABE or MSCV constructs were enriched by puromycin…”
MethodResultInfluentialSenescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295
“It was believed for years that telomere maintenance by the activation of telomerase or alternative mechanisms is one of the components required to convert a normal human cell into a cancer cel”
BackgroundAbd Elmageed, Z. Y., Yang, Y., Thomas, R., Ranjan, M., Mondal, D., Moroz, K., Fang, Z., Rezk, B. M., Moparty, K., Sikka, S. C., et al. (2014) · Stem Cells · doi:10.1002/stem.1619 · Cited by 295
Coming Full Circle—From Endless Complexity to Simplicity and Back Again
Weinberg, R. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.004 · Cited by 294
Self-citationHuman papillomaviruses: targeting differentiating epithelial cells for malignant transformation
Fehrmann, F., & Laimins, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206554 · Cited by 292
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600065103 · Cited by 294
Phospholipase D in cell proliferation and cancer.
Foster, D. A., & Xu, L. (2003) · PubMed · Cited by 334
Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0346 · Cited by 291
Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H., & Schneider, M. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191169098 · Cited by 289
Modeling High-Grade Serous Ovarian Carcinogenesis from the Fallopian Tube
Karst, A. M., Levanon, K., & Drapkin, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017300108 · Cited by 280
“We generated immortal cells (FT33) by transducing first-passage FTSECs with a retroviral vector encoding hTERT, the catalytic subunit of telomerase, which maintains telomere ends and stalls replicative senescence (20).”
BackgroundMethodHuman mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase
Zhao, J. J., Gjoerup, O. V., Subramanian, R. R., Cheng, Y., Chen, W., Roberts, T. M., & Hahn, W. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00088-6 · Cited by 279
Self-citationSonoda, Y., Ozawa, T., Hirose, Y., Aldape, K. D., McMahon, M., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 298
Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer
Bruntz, R. C., Lindsley, C. W., & Brown, H. A. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009217 · Cited by 276
Gewin, L., Myers, H., Kiyono, T., & Galloway, D. A. (2004) · Genes & Development · doi:10.1101/gad.1214704 · Cited by 277
“2000), inactivation of p53 is insufficient to induce telomerase (Hahn et al. 1999a; Opitz et al. 2001).”
BackgroundInfluentialFoster, D. A., Yellen, P., Xu, L., & Saqcena, M. (2010) · Genes & Cancer · doi:10.1177/1947601910392989 · Cited by 275
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
Poole, J. C., Andrews, L. G., & Tollefsbol, T. O. (2001) · Gene · doi:10.1016/s0378-1119(01)00440-1 · Cited by 274
Ding, H., Roncari, L., Shannon, P. T., Wu, X., Lau, N. C., Karásková, J., Gutmann, D. H., Squire, J. A., Nagy, A., & Guha, A. (2001) · PubMed · Cited by 271
A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity
Kolfschoten, I. G. M., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., Voorhoeve, P. M., & Agami, R. (2005) · Cell · doi:10.1016/j.cell.2005.04.017 · Cited by 273
Self-citationA Genetically Defined Model for Human Ovarian Cancer
Liu, J., Yang, G., Thompson-Lanza, J. A., Glassman, A., Hayes, K., Patterson, A., Marquez, R. T., Auersperg, N., Yu, Y., Hahn, W. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3380 · Cited by 273
Self-citationAdriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271
Johnson, F. B., Marciniak, R. A., McVey, M., Stewart, S. A., Hahn, W. C., & Guarente, L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.905 · Cited by 269
Self-citationMatsuoka, M., & Jeang, K.-T. (2011) · Oncogene · doi:10.1038/onc.2010.537 · Cited by 268
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 266
From cells to organisms: can we learn about aging from cells in culture?
Campisi, J. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00230-8 · Cited by 267
Craig, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402416 · Cited by 266
The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
Lee, Y.-S., Lim, K.-H., Guo, X., Kawaguchi, Y., Gao, Y., Barrientos, T., Ordentlich, P., Wang, X.-F., Counter, C. M., & Yao, T.-P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0188 · Cited by 260
“Specifically, primary human cells from various origins were transformed into tumor cells by serial introduction of human telomerase (hTERT), SV40 early region, which contains large T antigen and small t antigen, and finally oncogenic Ras (32).”
BackgroundSelf-citationAkagi, T., Sasai, K., & Hanafusa, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834876100 · Cited by 260
Schardt, J. A., Meyer, M., Hartmann, C. H., Schubert, F., Schmidt-Kittler, O., Fuhrmann, C., Polzer, B., Petronio, M., Eils, R., & Klein, C. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.003 · Cited by 259
Immortalization and transformation of primary human airway epithelial cells by gene transfer
Lundberg, A. S., Randell, S. H., Stewart, S. A., Elenbaas, B., Hartwell, K. A., Brooks, M. W., Fleming, M. D., Olsen, J. C., Miller, S. W., Weinberg, R. A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205550 · Cited by 258
Self-citationT Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and Tumorigenesis
Sullivan, C. S., & Pipas, J. M. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.179-202.2002 · Cited by 258
Li, R., Sonik, A., Stindl, R., Rasnick, D., & Duesberg, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3236 · Cited by 258
Generation and in Vitro Differentiation of a Spermatogonial Cell Line
Feng, L.-X., Chen, Y., Dettin, L., Pera, R. A. R., Herr, J. C., Goldberg, E., & Dym, M. (2002) · Science · doi:10.1126/science.1073162 · Cited by 258
Funes, J. M., Quintero, M., Henderson, S., Martinez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700690104 · Cited by 256
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
Minev, B., Hipp, J., Firat, H., Schmidt, J. D., Langlade-Demoyen, P., & Zanetti, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070560797 · Cited by 255
Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells
Lim, K.-H., O'Hayer, K., Adam, S. J., Kendall, S. D., Campbell, P. M., Der, C. J., & Counter, C. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.023 · Cited by 250
Self-citationKelland, L. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.024 · Cited by 252
Jones, J. M., Morrell, J. C., & Gould, S. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200304111 · Cited by 250
Ral-GTPases: approaching their 15 minutes of fame.
Feig, L. A. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00152-1 · Cited by 249
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Phan, A. T., Guéron, M., & Leroy, J.-L. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3613 · Cited by 248
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.